Press ESC to close

Peptide Lab App Log in Articles News Guide Products
More Peptide Tracker Calculator Best Calculators Peptide Statistics Contact Newsletter
Français English Deutsch Español Português العربية Italiano Polski 한국어 日本語 中文 Русский Nederlands Čeština Svenska Türkçe

Peptide Encyclopedia

Our encyclopedia of the most researched peptides. Mechanisms of action, studied benefits and research status for each peptide.

60 Guide
MK-677 (Ibutamoren)
Not approved for human use in any jurisdiction. Investigational compound, development discontinued.

MK-677 (Ibutamoren)

Ibutamoren mesylate (MK-0677, L-163,191)

MOTS-c
Research peptide — not approved for human use

MOTS-c

Mitochondrial Open Reading Frame of the 12S rRNA type-c

NAD+
Coenzyme studied in humans mainly through oral precursors. Injectable forms have very limited published human data and are not approved for anti-aging use.

NAD+

Nicotinamide Adenine Dinucleotide

Orforglipron
FDA approved April 2026 for chronic weight management (brand name Foundayo); authorized in the UK by the MHRA in August 2026; positive CHMP opinion in the EU in October 2026 (European Commission decision pending); other indications and territories under review

Orforglipron

Orforglipron (development codes LY3502970 and OWL833; brand name Foundayo)

Oxytocin
Approved as an injectable medicine in obstetrics; intranasal and behavioral uses remain investigational

Oxytocin

Oxytocin (Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH₂)

Pemvidutide
Investigational. Not approved by the FDA or EMA. Phase 3 under way in MASH; Phase 2 completed in obesity; Phase 2 ongoing in alcohol use disorder.

Pemvidutide

Pemvidutide (formerly ALT-801), balanced 1:1 GLP-1 receptor / glucagon receptor dual agonist

Pinealon
Preclinical research peptide. Not approved as a medicine by the FDA or EMA.

Pinealon

L-glutamyl-L-aspartyl-L-arginine (Glu-Asp-Arg, EDR)

PT-141
FDA Approved (Vyleesi)

PT-141

Bremelanotide (Vyleesi®)

Retatrutide
Phase 3 Clinical Trials

Retatrutide

LY3437943 (Eli Lilly)

Selank
Research peptide — approved in Russia; not FDA/EMA approved

Selank

Threonyl-Lysyl-Prolyl-Arginyl-Prolyl-Glycyl-Proline (tuftsin analog TP-7)

Semaglutide
FDA/EMA Approved

Semaglutide

GLP-1 Receptor Agonist

Semax
Research peptide — approved as a medicine only in Russia; not approved by the FDA or EMA

Semax

Semax (Met-Glu-His-Phe-Pro-Gly-Pro), a synthetic analog of ACTH(4-10)